XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of option activity
          
       Weighted 
       Average 
   Number of   Exercise 
   Options   Price 
Outstanding at December 31, 2023   481,858   $10.41 
Granted   113,000    6.10 
Forfeited   (2,200)   10.74 
Outstanding at March 31, 2024   592,658   $8.48 
Schedule of assumptions for options granted
       
    Three months ended March 31,
    2024   2023
Expected volatility   90.28% - 90.37%   94.51%
Expected term   7 Years   7 Years
Risk-free interest rate   4.01% - 4.25%   3.55%
Weighted-average FV   $4.88   $14.28
Schedule of restricted stock awards
          
Nonvested at December 31, 2023   1,238   $20.17 
Vested   (310)   20.17 
Nonvested at March 31, 2024   928   $20.17 
Schedule of warrants outstanding
          
   Number of Warrants   Weighted Average Exercise Price 
Outstanding at December 31, 2023   610,745   $9.80 
Granted        
Exercised   (40,027)   6.30 
Outstanding at March 31, 2024   570,718   $10.05 
Exercisable at March 31, 2024   570,718   $10.05